Solaris Life Sciences products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Rawat · Pakistan
Rawat/Islamabad pharmaceutical manufacturer focused on solid oral, dry-powder and topical dosage forms with GMP-aligned manufacturing operations.
Solaris Life Sciences products in Pakistan
Solaris Life Sciences Private Limited has 58 medicine presentations registered in Pakistan under 33 brands, covering 27 generic medicines. Most of its products are in Anti-infectives, Gastrointestinal & hepatology and Hematology & thrombosis. Its brands with the most registered strengths and packs are Drocort (Hydrocortisone), Infecef (Ceftriaxone), Referox (Deferasirox) and Colemset (Colistimethate sodium). 57 products have an official DRAP price on MedInfoBase. See all 33 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Solaris Life Sciences (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 08, Street No. S-1, RCCI Industrial Estate, Rawat, Islamabad, Pakistan
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 63%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Solaris Life Sciences Private Limited, is priced against the market
49 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Antis | Loratadine | 10 mg | Tablet | 1x10's | 136771 | PKR 148.70 | PKR 14.87/tablet | 🔒 Pharma Pro |
| Axiflox | Moxifloxacin | 400 mg | Tablet | 1x5's | 136676 | PKR 981.00 | PKR 196.20/tablet | 🔒 Pharma Pro |
| Colemset | Colistimethate sodium | 1 MIU (≈34 mg colistin base activity) | Injection | 1's | 123688 | PKR 1,199.81 | PKR 1,199.81/vial/unit | 🔒 Pharma Pro |
| Colemset | Colistimethate sodium | 2 MIU (≈68 mg colistin base activity) | Injection | 1's | 123689 | PKR 2,000.07 | PKR 2,000.07/vial/unit | 🔒 Pharma Pro |
| Colemset | Colistimethate sodium | 4.5 MIU | Injection | 1's | 124113 | PKR 4,501.60 | PKR 4,501.60/vial/unit | 🔒 Pharma Pro |
| Colemset-3MIU | Colistimethate sodium | 3 MIU (approx. 100 mg colistin base activity) | Injection | 1's | 124112 | PKR 3,000.68 | PKR 3,000.68/vial/unit | No comparator |
| Dogrel | Clopidogrel | 75 mg | Tablet | 10's | 124486 | PKR 301.97 | PKR 30.20/tablet | 🔒 Pharma Pro |
| Dpsyl 50mg SachetRegistry verified | Diclofenac potassium | — | — | — | 136673Official source ↗ | No indexed price | — | — |
| Dpsyl 50mg TabletRegistry verified | Diclofenac Potassium | — | — | — | 124121Official source ↗ | No indexed price | — | — |
| Drocort | Hydrocortisone | 100 mg | Injection | 1 | 123683 | PKR 90.80 | — | No comparator |
| Drocort | Hydrocortisone | 100 mg | Injection | 1's | 123683 | No indexed price | — | No comparator |
| Drocort | Hydrocortisone | 250 mg | Injection | 1's | 123684 | PKR 166.57 | PKR 166.57/vial/unit | 🔒 Pharma Pro |
| Drocort | Hydrocortisone | 500 mg | Injection | 1's | 123685 | PKR 358.65 | PKR 358.65/vial/unit | 🔒 Pharma Pro |
| Enzapin 10mg ODT TabletRegistry verified | Olanzapine (as citrate) | — | — | — | 124126Official source ↗ | No indexed price | — | — |
| Etoroxib 60mg TabletRegistry verified | Etoricoxib | — | — | — | 121749Official source ↗ | No indexed price | — | — |
| Etoroxib 90mg TabletRegistry verified | Etoricoxib | — | — | — | 121750Official source ↗ | No indexed price | — | — |
| Exilo 30mg CapsuleRegistry verified | Dexlansoprazole Dual Delayed Release Pellets Eq. to Dexlansoprazole | — | — | — | 126389Official source ↗ | No indexed price | — | — |
| Exilo 60mg CapsuleRegistry verified | Dexlansoprazole | — | — | — | 126390Official source ↗ | No indexed price | — | — |
| Forcan | Fluconazole | 150 mg | Capsule | 4's | 121740 | PKR 578.06 | PKR 144.52/capsule | 🔒 Pharma Pro |
| Forcan | Fluconazole | 150 mg | Capsule | 1's | 121740 | PKR 144.49 | PKR 144.49/capsule | 🔒 Pharma Pro |
| Forcan-50mg/5ml | Fluconazole | 50 mg/5 mL | Dry suspension | 35ml | 121739 | PKR 433.67 | PKR 12.39/mL | 🔒 Pharma Pro |
| Infecef | Ceftriaxone | 250 mg | Injection | 1's | 123697 | PKR 208.58 | PKR 208.58/vial/unit | 🔒 Pharma Pro |
| Infecef | Ceftriaxone | 500 mg | Injection | 1's | 123698 | PKR 351.07 | PKR 351.07/vial/unit | 🔒 Pharma Pro |
| Infecef | Ceftriaxone | 500 mg | IM injection | 1's | 123699 | PKR 351.07 | PKR 351.07/vial/unit | 🔒 Pharma Pro |
| Infecef | Ceftriaxone | 1 g | Injection | 1's | 123700 | PKR 662.90 | PKR 662.90/vial/unit | 🔒 Pharma Pro |
| Leteron-2.5mg | Letrozole | 2.5 mg | Tablet | 30's | 124867 | PKR 12,390.65 | PKR 413.02/tablet | 🔒 Pharma Pro |
| Linzasol 100mg TabletRegistry verified | Linzagolix Choline | — | — | — | 135353Official source ↗ | No indexed price | — | — |
| Linzasol 200mg TabletRegistry verified | Linzagolix Choline | — | — | — | 135354Official source ↗ | No indexed price | — | — |
| Lozili | Linezolid | 600 mg | Infusion | 1's | 123692 | PKR 1,239.06 | PKR 1,239.06/vial/unit | No comparator |
| Lozili | Linezolid | 100 mg/5 mL | Suspension | 60ml | 124108 | PKR 722.79 | PKR 12.05/mL | 🔒 Pharma Pro |
| Maropen | Meropenem | 500 mg | Injection | 1's | 123681 | PKR 2,209.67 | PKR 2,209.67/vial/unit | 🔒 Pharma Pro |
| Maropen | Meropenem | 1 g | Injection | 1's | 123682 | PKR 4,130.22 | PKR 4,130.22/vial/unit | 🔒 Pharma Pro |
| Medlopin | Amlodipine | 5 mg | Tablet | 20's | 121741 | PKR 185.86 | PKR 9.29/tablet | 🔒 Pharma Pro |
| Medlopin | Amlodipine | 10 mg | Tablet | 20's | 121742 | PKR 299.44 | PKR 14.97/tablet | 🔒 Pharma Pro |
| Negz 20mg CapsulesRegistry verified | Esomeprazole Magnesium Trihydrate Enteric coated Pellets of eq. to Esomeprazole | — | — | — | 124883Official source ↗ | No indexed price | — | — |
| Negz 40mg CapsulesRegistry verified | Esomeprazole | — | — | — | 124884Official source ↗ | No indexed price | — | — |
| Negz 40mg Injection IVRegistry verified | Esomeprazole as Sodium | — | — | — | 123748Official source ↗ | No indexed price | — | — |
| Neusiloc | Ondansetron | 4 mg/5 mL | Syrup | 1's | 123693 | PKR 1,032.55 | PKR 1,032.55/unit | No comparator |
| Neusiloc | Ondansetron | 8 mg/4 mL | Injection | 5's | 123694 | PKR 5,338.30 | PKR 1,067.66/vial/unit | 🔒 Pharma Pro |
| Neusiloc | Ondansetron | 8 mg/4 mL | Injection | 1's | 123694 | PKR 1,067.66 | PKR 1,067.66/vial/unit | 🔒 Pharma Pro |
| Ovag | Clotrimazole | 2% | Cream | 35gm | 124111 | PKR 322.16 | PKR 9.20/g | 🔒 Pharma Pro |
| OVAG 1% w/v Topical LotionRegistry verified | Clotrimazole | — | — | — | 124128Official source ↗ | No indexed price | — | — |
| OVAG 10%w/w Vaginal CreamRegistry verified | Clotrimazole | — | — | — | 131961Official source ↗ | No indexed price | — | — |
| Paciline | Piperacillin + tazobactam | 2 g + 0.25 g | Injection | 1's | 124115 | PKR 702.14 | PKR 702.14/vial/unit | 🔒 Pharma Pro |
| Paciline | Piperacillin + tazobactam | 4 g + 0.5 g | Injection | 1's | 124116 | PKR 1,596.33 | PKR 1,596.33/vial/unit | 🔒 Pharma Pro |
| PMT | Permethrin | 5% | Cream | 30gm | 126396 | PKR 113.42 | PKR 3.78/g | 🔒 Pharma Pro |
| PTZ 40mg Injection IVRegistry verified | Pantoprazole sodium sesquihydrate 22.56mg eq to pantoprazole | — | — | — | 136714Official source ↗ | No indexed price | — | — |
| Referox | Deferasirox | 250 mg | Tablet | 28's | 123753 | PKR 9,057.56 | PKR 323.48/tablet | 🔒 Pharma Pro |
| Referox | Deferasirox | 500 mg | Tablet | 28's | 123754 | PKR 15,033.98 | PKR 536.93/tablet | 🔒 Pharma Pro |
| Referox | Deferasirox | 180 mg | Tablet | 30's | 124109 | PKR 11,188.75 | PKR 372.96/tablet | 🔒 Pharma Pro |
All 33 Solaris Life Sciences brands in Pakistan
- Antis Loratadine · 10 mg tablet
- Axiflox Moxifloxacin · 400 mg tablet
- Colemset Colistimethate sodium · 1 MIU (≈34 mg colistin base activity) injection, 2 MIU (≈68 mg colistin base activity) injection, 4.5 MIU injection
- Colemset-3MIU Colistimethate sodium · 3 MIU (approx. 100 mg colistin base activity) injection
- Dogrel Clopidogrel · 75 mg tablet
- Drocort Hydrocortisone · 100 mg injection, 250 mg injection, 500 mg injection
- Forcan Fluconazole · 150 mg capsule
- Forcan-50mg/5ml Fluconazole · 50 mg/5 mL suspension
- Infecef Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Leteron-2.5mg Letrozole · 2.5 mg tablet
- Lozili Linezolid · 100 mg/5 mL suspension, 600 mg infusion
- Maropen Meropenem · 1 g injection, 500 mg injection
- Medlopin Amlodipine · 10 mg tablet, 5 mg tablet
- Neusiloc Ondansetron · 4 mg/5 mL syrup, 8 mg/4 mL injection
- Ovag Clotrimazole · 2% cream
- Paciline Piperacillin + tazobactam · 2 g + 0.25 g injection, 4 g + 0.5 g injection
- PMT Permethrin · 5% cream
- Referox Deferasirox · 180 mg tablet, 250 mg tablet, 360 mg tablet
- Satracur Atracurium besylate · 50 mg/5 mL (10 mg/mL) infusion
- Silvezin Silver sulfadiazine · 1 % cream, 1% cream
- Solexime Cefixime · 100 mg/5 mL suspension, 400 mg capsule
- Solexime DS Cefixime · 200 mg suspension
- Solipcin-250 Ciprofloxacin · 250 mg tablet
- Solipcin-500 Ciprofloxacin · 500 mg tablet
- Solithro Azithromycin · 250 mg capsule
- Solithro- Dry Susp Azithromycin · 200 mg/5 mL suspension
- Tacrimus Tacrolimus · 0.5 mg capsule, 1 mg capsule, 5 mg capsule
- Uncinq Omeprazole · 40 mg injection
- Vetirac Levetiracetam · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Vetrac Levetiracetam · 1000 mg tablet
- Vifcal- Soft Cholecalciferol · 50000 IU capsule
- Xempum Omeprazole enteric coated pellets · 20 mg capsule, 40 mg capsule
- Zolchem Zoledronic acid · 5 mg infusion
Solaris Life Sciences: common questions
How many products does Solaris Life Sciences have in Pakistan?
Solaris Life Sciences Private Limited has 58 registered medicine presentations in Pakistan, sold under 33 brands and covering 27 generic medicines.
What are the main brands of Solaris Life Sciences?
By number of registered strengths and packs, its largest brands are Drocort (Hydrocortisone), Infecef (Ceftriaxone), Referox (Deferasirox), Colemset (Colistimethate sodium) and Neusiloc (Ondansetron). This is not a sales ranking.
Which therapy areas does Solaris Life Sciences cover?
The most products are in Anti-infectives (29), Gastrointestinal & hepatology (6), Hematology & thrombosis (5), Dermatology (4) and Oncology & immunology (4).
Where can I see Solaris Life Sciences medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.